DJIA 17,593.42 -4.78 -0.03%
NASDAQ 5,113.79 -1.59 -0.03%
S&P 500 2,099.30 1.26 0.06%
market minute promo


27.58 0.20 (0.73%)

Quote as of

company name or ticker

Recent Quotes

INSM $27.58 0.73%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.28
Previous Close $27.38
Daily Range $27.15 - $27.62
52-Week Range $11.25 - $27.89
Market Cap $1.7B
P/E Ratio -13.49
Dividend (Yield) $0.00 (0.0%)
Volume 8,983
Average Daily Volume 380,928
Current FY EPS -$2.01




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Stocks Hitting 52-Week Highs

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

See More INSM News...

INSM's Top Competitors

INSM $27.58 (0.73%)
Current stock: INSM
AMGN $175.30 (-0.17%)
Current stock: AMGN
GILD $119.42 (-0.15%)
Current stock: GILD
BIIB $328.84 (1.37%)
Current stock: BIIB